Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate the efficacy and safety of cetuximab, docetaxel,
cisplatin combination as induction therapy in locally advanced head and neck squamous cell
carcinoma.